| Feb 4 2022 |
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts |
Epstein Becker & Green, P.C. |
| Feb 4 2022 |
Opioid Update: Court Denies Pharmacies’ Motion for Certification of An Interlocutory Appeal |
Squire Patton Boggs (US) LLP |
| Feb 4 2022 |
McDermottPlus Check-Up: February 4, 2022 |
McDermott Will & Schulte LLP |
| Feb 4 2022 |
Sixth Circuit Awards Attorney Fees to Multiple Qui Tam Relators |
Squire Patton Boggs (US) LLP |
| Feb 4 2022 |
Mississippi Enacts Medical Marijuana Law |
Jackson Lewis P.C. |
| Feb 4 2022 |
Global Private Equity- Spotlight on the Industry: What’s on The Horizon for 2022: Trends in Global Healthcare Private Equity |
McDermott Will & Schulte LLP |
| Feb 4 2022 |
Erasing the Stigma — Angela Han [PODCAST] |
Major Lindsey & Africa |
| Feb 3 2022 |
COVID-19 Vaccine Update – February 2022 |
Robinson & Cole LLP |
| Feb 3 2022 |
Oregon Health Authority Adopts COVID-19 Vaccination and Masking Rules in Healthcare and K-12 Education |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 3 2022 |
Highest French Administrative Court Freezes Ban on CBD Flowers and Leaves |
Squire Patton Boggs (US) LLP |
| Feb 3 2022 |
Roetzel HealthLaw HotSpot: Basics of a Healthcare Contract: When Do You Actually Have One and What Happens if It's Breached? [VIDEO] |
Roetzel & Andress LPA |
| Feb 3 2022 |
Global Private Equity- Spotlight on the Industry: The Need for Speed: Critical Issues Facing Healthcare Private Equity Buyers [VIDEO] |
McDermott Will & Schulte LLP |
| Feb 3 2022 |
Health Care IoT Devices Pose Risk to Patient Care |
Robinson & Cole LLP |
| Feb 3 2022 |
Expedited Renewal Processing for Foreign Nationals in Healthcare |
Jackson Lewis P.C. |
| Feb 3 2022 |
EPA Seeks Participants for SBAR Panel on TSCA Reporting and Recordkeeping Rule for PFAS |
Bergeson & Campbell, P.C. |
| Feb 3 2022 |
Medical Prescription Delivery by Drone Could Be Right Around the Corner |
Robinson & Cole LLP |
| Feb 3 2022 |
DOJ Releases FY 2021 False Claims Act Recoveries: A Record-Shattering Year for Health Care and Life Sciences Enforcement, with Over $5 Billion Collected |
Epstein Becker & Green, P.C. |
| Feb 2 2022 |
False Claims Act Settlements and Judgments Exceed $5.6 Billion in Fiscal Year 2021 |
Mintz |
| Feb 2 2022 |
New Jersey Takes Aggressive Action Against Alleged HIPAA Violations |
Epstein Becker & Green, P.C. |
| Feb 2 2022 |
Do I Need an Autopsy for Medical Malpractice Death Lawsuit? |
Buckfire Law |
| Feb 2 2022 |
What to Expect as OIG and CMS Audits Focus on COVID-19 Testing? |
Womble Bond Dickinson (US) LLP |
| Feb 2 2022 |
Groundbreaking Expansion of Medicaid Workability Program On the Way |
Norris McLaughlin P.A. |
| Feb 1 2022 |
Skyline Fraud Charges Serve as a Warning to Inexperienced Operators |
Bradley Arant Boult Cummings LLP |
| Feb 1 2022 |
What’s Next for OSHA Rulemaking on COVID-19 and Other Infectious Diseases |
Beveridge & Diamond PC |
| Feb 1 2022 |
Ohio Appeals Court Reinforces a Trial Court’s Ability to Modify Noncompete Agreements |
Jackson Lewis P.C. |
| Feb 1 2022 |
Mississippi Senate Counters House Proposal on Income Tax Reform |
Jones Walker LLP |
| Feb 1 2022 |
Gold Dome Report – Legislative Day 9 |
Nelson Mullins |
| Feb 1 2022 |
The 2021 Mental Health Parity Grades Are In – Everybody Failed |
Jackson Lewis P.C. |
| Feb 1 2022 |
Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know |
Foley & Lardner LLP |
| Feb 1 2022 |
State Law Privacy Video Series | Healthcare Entities and Health Data [VIDEO] |
McDermott Will & Schulte LLP |
| Feb 1 2022 |
FDA Provides Video Overview of FASTER Act |
Keller and Heckman LLP |
| Feb 1 2022 |
Top 5 Legal Issues in Digital Health to Watch for in 2022 |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 1 2022 |
Eliminating Kickbacks in Recovery Act (EKRA): 2021 Highlights |
Greenberg Traurig, LLP |
| Feb 1 2022 |
Unpacking Averages: Assessing the Racial Composition of Drug Clinical Trial Subjects |
Epstein Becker & Green, P.C. |
| Feb 1 2022 |
Up Front Discounts are Straight Up Fraud: Whistleblowers Receive $2.6 Million for Reporting Pharmaceutical Kickbacks |
Tycko & Zavareei LLP |
